TY - BOOK AU - Tauber, A. I. PY - 2017 DA - 2017// TI - Immunity: the Evolution of an Idea PB - Oxford University Press CY - Oxford UR - https://doi.org/10.1093/acprof:oso/9780190651244.001.0001 DO - 10.1093/acprof:oso/9780190651244.001.0001 ID - Tauber2017 ER - TY - JOUR AU - Bakács, T. AU - Mehrishi, J. N. AU - Szabados, T. AU - Varga, L. AU - Szabó, M. AU - Tusnády, G. PY - 2007 DA - 2007// TI - T cells survey the stability of the self: a testable hypothesis on the homeostatic role of TCR-MHC interactions JO - Int Arch Allergy and Immunol VL - 144 UR - https://doi.org/10.1159/000103282 DO - 10.1159/000103282 ID - Bakács2007 ER - TY - JOUR AU - Szabados, T. AU - Bakács, T. PY - 2011 DA - 2011// TI - Sufficient to recognize self to attack non-self: blueprint for a one-signal T cell model JO - J Biol Syst VL - 19 UR - https://doi.org/10.1142/S0218339011003919 DO - 10.1142/S0218339011003919 ID - Szabados2011 ER - TY - JOUR AU - Topalian, S. L. PY - 2017 DA - 2017// TI - Targeting immune checkpoints in cancer therapy JO - Jama VL - 318 UR - https://doi.org/10.1001/jama.2017.14155 DO - 10.1001/jama.2017.14155 ID - Topalian2017 ER - TY - JOUR AU - Kelly, P. N. PY - 2018 DA - 2018// TI - The Cancer Immunotherapy Revolution JO - Science VL - 359 UR - https://doi.org/10.1126/science.359.6382.1344 DO - 10.1126/science.359.6382.1344 ID - Kelly2018 ER - TY - JOUR AU - Puzanov, I. AU - Diab, A. AU - Abdallah, K. AU - Bingham, C. AU - Brogdon, C. AU - Dadu, R. AU - Hamad, L. AU - Kim, S. AU - Lacouture, M. AU - LeBoeuf, N. PY - 2017 DA - 2017// TI - Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0300-z DO - 10.1186/s40425-017-0300-z ID - Puzanov2017 ER - TY - JOUR AU - Brahmer, J. R. AU - Lacchetti, C. AU - Thompson, J. A. PY - 2018 DA - 2018// TI - Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary JO - J Oncol Pract VL - 14 UR - https://doi.org/10.1200/JOP.18.00005 DO - 10.1200/JOP.18.00005 ID - Brahmer2018 ER - TY - JOUR AU - Celada, F. AU - Seiden, P. E. PY - 1992 DA - 1992// TI - A computer model of cellular interactions in the immune system JO - Immunol Today VL - 13 UR - https://doi.org/10.1016/0167-5699(92)90135-T DO - 10.1016/0167-5699(92)90135-T ID - Celada1992 ER - TY - JOUR AU - Bonabeau, E. PY - 2002 DA - 2002// TI - Agent-based modeling: Methods and techniques for simulating human systems JO - Proc Natl Acad Sci VL - 99 UR - https://doi.org/10.1073/pnas.082080899 DO - 10.1073/pnas.082080899 ID - Bonabeau2002 ER - TY - JOUR AU - Germain, R. N. AU - Meier-Schellersheim, M. AU - Nita-Lazar, A. AU - Fraser, I. D. C. PY - 2011 DA - 2011// TI - Systems biology in immunology – A computational modeling perspective JO - Annu Rev Immunol VL - 29 UR - https://doi.org/10.1146/annurev-immunol-030409-101317 DO - 10.1146/annurev-immunol-030409-101317 ID - Germain2011 ER - TY - JOUR AU - Bretscher, P. AU - Cohn, M. PY - 1970 DA - 1970// TI - A theory of self-nonself discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively JO - Science VL - 169 UR - https://doi.org/10.1126/science.169.3950.1042 DO - 10.1126/science.169.3950.1042 ID - Bretscher1970 ER - TY - BOOK AU - Janeway, C. AU - Murphy, K. P. AU - Travers, P. AU - Walport, M. PY - 2008 DA - 2008// TI - Immunobiology PB - Garland Science CY - New York ID - Janeway2008 ER - TY - BOOK AU - Paul, W. E. PY - 2008 DA - 2008// TI - Fundamental immunology PB - Wilkins CY - Philadelphia ID - Paul2008 ER - TY - JOUR AU - Faro, J. AU - Velasco, S. AU - González-Fernández, A. AU - Bandeira, A. PY - 2004 DA - 2004// TI - The impact of thymic antigen diversity on the size of the selected t cell repertoire JO - J Immunol VL - 172 UR - https://doi.org/10.4049/jimmunol.172.4.2247 DO - 10.4049/jimmunol.172.4.2247 ID - Faro2004 ER - TY - JOUR AU - Langman, R. E. PY - 1992 DA - 1992// TI - Molecular economy and antibody function: the evolution of a Protecton JO - Int J Clin Lab Res. VL - 22 UR - https://doi.org/10.1007/BF02591398 DO - 10.1007/BF02591398 ID - Langman1992 ER - TY - JOUR AU - Bredberg, A. PY - 2009 DA - 2009// TI - Cancer resistance and peto’s paradox JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0901953106 DO - 10.1073/pnas.0901953106 ID - Bredberg2009 ER - TY - BOOK AU - AK, A. K. A. AU - Lichtman, A. H. PY - 2004 DA - 2004// TI - Basic Immunology: Functions and Disorders of the Immune System, 2nd edn. PB - Saunders CY - Philadelphia ID - AK2004 ER - TY - JOUR AU - Folcik, V. A. AU - An, G. C. AU - Orosz, C. G. PY - 2007 DA - 2007// TI - The Basic Immune Simulator: An agent-based model to study the interactions between innate and adaptive immunity JO - Theor Biol Med Model VL - 4 UR - https://doi.org/10.1186/1742-4682-4-39 DO - 10.1186/1742-4682-4-39 ID - Folcik2007 ER - TY - JOUR AU - Castiglione, F. AU - Bernaschi, M. AU - Succi, S. PY - 1997 DA - 1997// TI - Simulating the immune response on a distributed parallel computer JO - Int J Mod Phys C VL - 8 UR - https://doi.org/10.1142/S0129183197000424 DO - 10.1142/S0129183197000424 ID - Castiglione1997 ER - TY - JOUR AU - Rapin, N. AU - Lund, O. AU - Bernaschi, M. AU - Castiglione, F. PY - 2010 DA - 2010// TI - Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system JO - PLoS ONE VL - 5 UR - https://doi.org/10.1371/journal.pone.0009862 DO - 10.1371/journal.pone.0009862 ID - Rapin2010 ER - TY - JOUR AU - Kalita, J. K. AU - Chandrashekar, K. AU - Hans, R. AU - Selvam, P. AU - Newell, M. K. PY - 2006 DA - 2006// TI - Computational modelling and simulation of the immune system JO - Int J Bioinform Res Appl VL - 2 UR - https://doi.org/10.1504/IJBRA.2006.009194 DO - 10.1504/IJBRA.2006.009194 ID - Kalita2006 ER - TY - JOUR AU - Kaufman, M. AU - Urbain, J. AU - Thomas, R. PY - 1985 DA - 1985// TI - Towards a logical analysis of immune response JO - J Theor Biol VL - 114 UR - https://doi.org/10.1016/S0022-5193(85)80042-4 DO - 10.1016/S0022-5193(85)80042-4 ID - Kaufman1985 ER - TY - JOUR AU - de Boer, R. J. AU - Perelson, A. S. PY - 1991 DA - 1991// TI - Size and connectivity as emergent properties of a developing immune network JO - J Theor Biol VL - 149 UR - https://doi.org/10.1016/S0022-5193(05)80313-3 DO - 10.1016/S0022-5193(05)80313-3 ID - de Boer1991 ER - TY - JOUR AU - Perelson, A. S. AU - Oster, G. F. PY - 1979 DA - 1979// TI - Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-nonself discrimination JO - J Theor Biol VL - 81 UR - https://doi.org/10.1016/0022-5193(79)90275-3 DO - 10.1016/0022-5193(79)90275-3 ID - Perelson1979 ER - TY - JOUR AU - Segel, L. A. AU - Perelson, A. S. PY - 1988 DA - 1988// TI - Computations in shape space: a new approach to immune network theory JO - Theor Immunol VL - 2 ID - Segel1988 ER - TY - JOUR AU - Celada, F. AU - Seiden, P. E. PY - 1996 DA - 1996// TI - Affinity maturation and hypermutation in a simulation of the humoral immune response JO - Eur J Immunol VL - 26 UR - https://doi.org/10.1002/eji.1830260626 DO - 10.1002/eji.1830260626 ID - Celada1996 ER - TY - JOUR AU - Mehrishi, J. N. AU - Szabó, M. AU - Bakács, T. PY - 2007 DA - 2007// TI - Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.02.078 DO - 10.1016/j.vaccine.2007.02.078 ID - Mehrishi2007 ER - TY - JOUR AU - Thimme, R. AU - Oldach, D. AU - Chang, K. M. AU - Steiger, C. AU - Ray, S. C. AU - Chisari, F. V. PY - 2001 DA - 2001// TI - Determinants of viral clearance and persistence during acute hepatitis C virus infection JO - J Exp Med VL - 194 UR - https://doi.org/10.1084/jem.194.10.1395 DO - 10.1084/jem.194.10.1395 ID - Thimme2001 ER - TY - JOUR AU - Eberl, G. AU - Colonna, M. AU - Di Santo, J. P. AU - McKenzie, A. N. PY - 2015 DA - 2015// TI - Innate lymphoid cells: A new paradigm in immunology JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa6566 DO - 10.1126/science.aaa6566 ID - Eberl2015 ER - TY - JOUR AU - Matzinger, P. PY - 2002 DA - 2002// TI - The danger model: a renewed sense of self JO - Science VL - 296 UR - https://doi.org/10.1126/science.1071059 DO - 10.1126/science.1071059 ID - Matzinger2002 ER - TY - BOOK AU - Chollet, F. PY - 2017 DA - 2017// TI - Deep learning with python PB - Manning CY - Shelter Island ID - Chollet2017 ER - TY - JOUR AU - Marino, S. AU - Hogue, I. B. AU - Ray, C. J. AU - Kirschner, D. E. PY - 2008 DA - 2008// TI - A methodology for performing global uncertainty and sensitivity analysis in systems biology JO - J Theor Biol VL - 254 UR - https://doi.org/10.1016/j.jtbi.2008.04.011 DO - 10.1016/j.jtbi.2008.04.011 ID - Marino2008 ER - TY - JOUR AU - Chan, C. AU - Billard, M. AU - Ramirez, S. A. AU - Schmidl, H. AU - Monson, E. AU - Kepler, T. B. PY - 2013 DA - 2013// TI - A model for migratory B cell oscillations from receptor down-regulation induced by external chemokine fields JO - Bull Math Biol VL - 75 UR - https://doi.org/10.1007/s11538-012-9799-9 DO - 10.1007/s11538-012-9799-9 ID - Chan2013 ER - TY - JOUR AU - Schulz, R. AU - Werner, B. AU - Behn, U. PY - 2014 DA - 2014// TI - Self-tolerance in a minimal model of the idiotypic network JO - Immune Syst Model Anal. VL - 5 ID - Schulz2014 ER - TY - JOUR AU - León, K. AU - Lage, A. AU - Carneiro, J. PY - 2003 DA - 2003// TI - Tolerance and immunity in a mathematical model of T-cell mediated suppression JO - J Theor Biol VL - 225 UR - https://doi.org/10.1016/S0022-5193(03)00226-1 DO - 10.1016/S0022-5193(03)00226-1 ID - León2003 ER - TY - JOUR AU - Chinen, T. AU - Kannan, A. K. AU - Levine, A. G. AU - Fan, X. AU - Klein, U. AU - Zheng, Y. AU - Gasteiger, G. AU - Feng, Y. AU - Fontenot, J. D. AU - Rudensky, A. Y. PY - 2016 DA - 2016// TI - An essential role for the IL-2 receptor in Treg cell function JO - Nat Immunol VL - 17 UR - https://doi.org/10.1038/ni.3540 DO - 10.1038/ni.3540 ID - Chinen2016 ER - TY - JOUR AU - Curran, M. A. AU - Callahan, M. K. AU - Subudhi, S. K. AU - Allison, J. P. PY - 2012 DA - 2012// TI - Response to Ipilimumab (Yervoy) and the TGN1412 catastrophe JO - Immunobiology VL - 217 UR - https://doi.org/10.1016/j.imbio.2011.11.001 DO - 10.1016/j.imbio.2011.11.001 ID - Curran2012 ER - TY - JOUR AU - Bertrand, A. AU - Kostine, M. AU - Barnetche, T. AU - Truchetet, M. -. E. AU - Schaeverbeke, T. PY - 2015 DA - 2015// TI - Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis JO - BMC Med VL - 13 UR - https://doi.org/10.1186/s12916-015-0455-8 DO - 10.1186/s12916-015-0455-8 ID - Bertrand2015 ER - TY - JOUR AU - Freitas, A. A. AU - Rocha, B. PY - 2000 DA - 2000// TI - Population biology of lymphocytes: the flight for survival JO - Annu Rev Immunol VL - 18 UR - https://doi.org/10.1146/annurev.immunol.18.1.83 DO - 10.1146/annurev.immunol.18.1.83 ID - Freitas2000 ER - TY - JOUR AU - Ellestad, K. K. AU - Lin, J. AU - Boon, L. AU - Anderson, C. C. PY - 2017 DA - 2017// TI - PD-1 controls tonic signaling and lymphopenia-induced proliferation of T lymphocytes JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01289 DO - 10.3389/fimmu.2017.01289 ID - Ellestad2017 ER - TY - JOUR AU - Ellestad, K. K. AU - Anderson, C. C. PY - 2017 DA - 2017// TI - Two strikes and you’re out? The pathogenic interplay of coinhibitor deficiency and lymphopenia-induced proliferation JO - J Immunol VL - 198 UR - https://doi.org/10.4049/jimmunol.1601884 DO - 10.4049/jimmunol.1601884 ID - Ellestad2017 ER - TY - JOUR AU - Ellestad, K. K. AU - Thangavelu, G. AU - Haile, Y. AU - Lin, J. AU - Boon, L. AU - Anderson, C. C. PY - 2018 DA - 2018// TI - Prior to Peripheral Tolerance, newly generated cD4 T cells Maintain Dangerous autoimmune Potential: Fas-and Perforin-independent autoimmunity controlled by Programmed Death-1 JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00012 DO - 10.3389/fimmu.2018.00012 ID - Ellestad2018 ER - TY - JOUR AU - Thangavelu, G. AU - Gill, R. G. AU - Boon, L. AU - Ellestad, K. K. AU - Anderson, C. C. PY - 2013 DA - 2013// TI - Control of in vivo collateral damage generated by T cell immunity JO - J Immunol VL - 191 UR - https://doi.org/10.4049/jimmunol.1203240 DO - 10.4049/jimmunol.1203240 ID - Thangavelu2013 ER - TY - JOUR AU - Cohen, I. R. PY - 1992 DA - 1992// TI - The cognitive paradigm and the immunological homunculus JO - Immunol Today VL - 13 UR - https://doi.org/10.1016/0167-5699(92)90024-2 DO - 10.1016/0167-5699(92)90024-2 ID - Cohen1992 ER - TY - JOUR AU - Allison, J. P. PY - 2015 DA - 2015// TI - Immune checkpoint blockade in cancer therapy: the 2015 lasker-debakey clinical medical research award JO - Jama VL - 314 UR - https://doi.org/10.1001/jama.2015.11929 DO - 10.1001/jama.2015.11929 ID - Allison2015 ER - TY - JOUR AU - Hoos, A. PY - 2016 DA - 2016// TI - Development of immuno-oncology drugs from CTLA4 to PD1 to the next generations JO - Nat Rev Drug Discov VL - 15 UR - https://doi.org/10.1038/nrd.2015.35 DO - 10.1038/nrd.2015.35 ID - Hoos2016 ER - TY - JOUR AU - Couzin-Frankel, J. PY - 2017 DA - 2017// TI - Autoimmune diseases surface after cancer treatment JO - Science VL - 358 UR - https://doi.org/10.1126/science.358.6365.852 DO - 10.1126/science.358.6365.852 ID - Couzin-Frankel2017 ER - TY - JOUR AU - Bakacs, T. AU - Mehrishi, J. N. AU - Moss, R. PY - 2012 DA - 2012// TI - Ipilimumab (Yervoy) and the TGN1412 catastrophe JO - Immunobiology VL - 217 UR - https://doi.org/10.1016/j.imbio.2011.07.005 DO - 10.1016/j.imbio.2011.07.005 ID - Bakacs2012 ER - TY - JOUR AU - Bakacs, T. AU - Mehrishi, J. N. AU - Szabo, M. AU - Moss, R. PY - 2012 DA - 2012// TI - Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy) JO - Pharmacol Res VL - 66 UR - https://doi.org/10.1016/j.phrs.2012.03.015 DO - 10.1016/j.phrs.2012.03.015 ID - Bakacs2012 ER - TY - JOUR AU - Slavin, S. AU - Moss, R. AU - Bakacs, T. PY - 2014 DA - 2014// TI - Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity JO - Pharmacol Res VL - 79 UR - https://doi.org/10.1016/j.phrs.2013.10.004 DO - 10.1016/j.phrs.2013.10.004 ID - Slavin2014 ER - TY - JOUR AU - Bakacs, T. AU - Mehrishi, J. N. PY - 2015 DA - 2015// TI - Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiency JO - Immunobiology VL - 220 UR - https://doi.org/10.1016/j.imbio.2014.11.019 DO - 10.1016/j.imbio.2014.11.019 ID - Bakacs2015 ER - TY - JOUR AU - Kleef, R. AU - Moss, W. AU - Szasz, A. M. AU - Bohdjalian, A. AU - Bakacs, T. PY - 2016 DA - 2016// TI - Near complete remission of pulmonary metastases in triple negative breast cancer (TNBC) using low-dose immune checkpoint (IC) inhibitors with high dose (HD) interleukin-2 (IL-2) and fever range hyperthermia JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.34.15_suppl.e23111 DO - 10.1200/JCO.2016.34.15_suppl.e23111 ID - Kleef2016 ER - TY - JOUR AU - Kleef, R. AU - Moss, R. AU - Szasz, A. M. AU - Bohdjalian, A. AU - Bojar, H. AU - Bakacs, T. PY - 2018 DA - 2018// TI - Complete clinical remission of stage iv triple-negative breast cancer lung metastasis administering low-dose immune checkpoint blockade in combination with hyperthermia and interleukin-2 JO - Integr Cancer Ther. VL - 4 UR - https://doi.org/10.1177/1534735418794867 DO - 10.1177/1534735418794867 ID - Kleef2018 ER - TY - BOOK AU - Fisher, R. A. PY - 1949 DA - 1949// TI - The design of experiments PB - Hafner CY - New York ID - Fisher1949 ER -